TH
INSIDER · HALO · HALOZYME THERAPEUTICS, INC. · PRESIDENT AND CEO
Torley Helen
Every open-market transaction filed under this name, Sep 9 to Oct 8.
Filings
19
0 buys · 19 sells
Bought
—
open market, at cost
Sold
$13M
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Oct 8 | HALO | HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sell | 200 | $110.51 | $22K | — |
| Oct 8 | HALO | HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sell | 11,900 | $110.00 | $1.3M | — |
| Oct 8 | HALO | HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sell | 3,090 | $108.91 | $337K | — |
| Oct 8 | HALO | HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sell | 4,810 | $108.18 | $520K | — |
| Oct 7 | HALO | HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sell | 200 | $113.69 | $23K | — |
| Oct 7 | HALO | HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sell | 900 | $112.78 | $102K | — |
| Oct 7 | HALO | HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sell | 10,300 | $111.84 | $1.2M | — |
| Oct 7 | HALO | HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sell | 8,600 | $111.03 | $955K | — |
| Oct 6 | HALO | HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sell | 1,780 | $110.81 | $197K | — |
| Oct 6 | HALO | HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sell | 9,920 | $109.89 | $1.1M | — |
| Oct 6 | HALO | HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sell | 6,000 | $109.33 | $656K | — |
| Oct 6 | HALO | HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sell | 2,300 | $107.90 | $248K | — |
| Sep 11 | HALO | HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sell | 4,508 | $107.55 | $485K | — |
| Sep 11 | HALO | HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sell | 15,492 | $107.15 | $1.7M | — |
| Sep 10 | HALO | HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sell | 5,412 | $107.58 | $582K | — |
| Sep 10 | HALO | HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sell | 14,588 | $107.01 | $1.6M | — |
| Sep 9 | HALO | HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sell | 100 | $108.67 | $11K | — |
| Sep 9 | HALO | HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sell | 6,596 | $107.82 | $711K | — |
| Sep 9 | HALO | HALOZYME THERAPEUTICS, INC. | PRESIDENT AND CEO | Sell | 13,304 | $107.22 | $1.4M | — |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.